Q3 2016 Holdings
Filed 2016-11-14 | 14 holdings | $526.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $388.0K | 55,008 | 73.7% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $25.5K | 784,159 | 4.8% |
| Versartis Inc | COM | 92529L102 | $25.0K | 2,039,223 | 4.7% |
| Edge Therapeutics Inc | COM | 279870109 | $24.4K | 2,344,868 | 4.6% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $17.3K | 1,377,497 | 3.3% |
| Dimension Therapeutics Inc | COM | 25433V105 | $16.5K | 2,059,283 | 3.1% |
| Alder Biopharmaceuticals Inc(ALDR1EUR) | COM | 014339105 | $7.6K | 230,954 | 1.4% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $6.6K | 193,944 | 1.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $6.1K | 132,674 | 1.2% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $4.2K | 400,381 | 0.8% |
| Aveo Pharmaceuticals Inc(AVEOEUR) | COM | 053588109 | $2.3K | 2,590,673 | 0.4% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM | 92840H202 | $1.5K | 352,950 | 0.3% |
| Trillium Therapeutics Inc | COM | 89620X506 | $1.2K | 80,759 | 0.2% |
| Inotek Pharmaceuticals Corp | COM | 45780V102 | $477 | 50,300 | 0.1% |